Heptares Therapeutics Reinforces Patent Protection for the Generation of Stabilized GPCRs

News   Nov 23, 2009

 
Heptares Therapeutics Reinforces Patent Protection for the Generation of Stabilized GPCRs
 
 
 

RELATED ARTICLES

Concept Life Sciences and Alderley Analytical Partner to provide Bioanalytical and DMPK Services

News

Companies announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.

READ MORE

All in a Droplet: Atomic Resolution of ALS Protein Resolved

News

Researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases of muscle and bone.

READ MORE

Artificial Enzyme Can Catalyze Reactions

News

Artificial Biology has taken a step forward as a study shows the catalytic ability of a synthetic enzyme.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE